

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 9.57633983 |
| 2 | leukocyte aggregation (GO:0070486) | 8.46187626 |
| 3 | thrombin receptor signaling pathway (GO:0070493) | 8.29256726 |
| 4 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 6.16780583 |
| 5 | glycoprotein catabolic process (GO:0006516) | 6.09528372 |
| 6 | rRNA transcription (GO:0009303) | 5.57022050 |
| 7 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.46123836 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.25901488 |
| 9 | adenosine receptor signaling pathway (GO:0001973) | 4.95438587 |
| 10 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.94946711 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.82810167 |
| 12 | negative regulation of norepinephrine secretion (GO:0010700) | 4.81658003 |
| 13 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 4.72097504 |
| 14 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 4.68499371 |
| 15 | regulation of platelet activation (GO:0010543) | 4.38068686 |
| 16 | blood coagulation, intrinsic pathway (GO:0007597) | 4.27199958 |
| 17 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.26383121 |
| 18 | erythrocyte maturation (GO:0043249) | 4.23741668 |
| 19 | regulation of female receptivity (GO:0045924) | 4.16963591 |
| 20 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 4.10828945 |
| 21 | negative regulation of heart rate (GO:0010459) | 4.06626181 |
| 22 | regulation of platelet aggregation (GO:0090330) | 4.06264213 |
| 23 | homotypic cell-cell adhesion (GO:0034109) | 4.04634238 |
| 24 | myelin assembly (GO:0032288) | 4.04288574 |
| 25 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.02607226 |
| 26 | platelet aggregation (GO:0070527) | 4.00394856 |
| 27 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.99363579 |
| 28 | positive regulation of vascular permeability (GO:0043117) | 3.98985982 |
| 29 | regulation of regulatory T cell differentiation (GO:0045589) | 3.86462428 |
| 30 | negative regulation of platelet activation (GO:0010544) | 3.80594888 |
| 31 | female mating behavior (GO:0060180) | 3.77617285 |
| 32 | negative regulation of appetite (GO:0032099) | 3.76619627 |
| 33 | negative regulation of response to food (GO:0032096) | 3.76619627 |
| 34 | regulation of lipoprotein metabolic process (GO:0050746) | 3.73491288 |
| 35 | induction of positive chemotaxis (GO:0050930) | 3.72889809 |
| 36 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.69109697 |
| 37 | negative regulation of protein localization to cell surface (GO:2000009) | 3.61655388 |
| 38 | reciprocal meiotic recombination (GO:0007131) | 3.61167260 |
| 39 | reciprocal DNA recombination (GO:0035825) | 3.61167260 |
| 40 | meiotic chromosome segregation (GO:0045132) | 3.60166701 |
| 41 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 3.55260785 |
| 42 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.54719621 |
| 43 | low-density lipoprotein particle remodeling (GO:0034374) | 3.51970311 |
| 44 | positive regulation of amino acid transport (GO:0051957) | 3.51420075 |
| 45 | purinergic receptor signaling pathway (GO:0035587) | 3.50039292 |
| 46 | purine nucleotide salvage (GO:0032261) | 3.38629422 |
| 47 | platelet degranulation (GO:0002576) | 3.37337669 |
| 48 | positive regulation of defense response to virus by host (GO:0002230) | 3.36166218 |
| 49 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.31842865 |
| 50 | regulation of glutamate secretion (GO:0014048) | 3.27913773 |
| 51 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 3.26578236 |
| 52 | neutrophil activation (GO:0042119) | 3.24423531 |
| 53 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.24185846 |
| 54 | regulation of norepinephrine secretion (GO:0014061) | 3.22635269 |
| 55 | macroautophagy (GO:0016236) | 3.21214114 |
| 56 | membrane invagination (GO:0010324) | 3.20327767 |
| 57 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.20130539 |
| 58 | positive regulation of mast cell activation (GO:0033005) | 3.18069686 |
| 59 | lipoxygenase pathway (GO:0019372) | 3.15826439 |
| 60 | beta-amyloid metabolic process (GO:0050435) | 3.12197731 |
| 61 | synaptonemal complex assembly (GO:0007130) | 3.10859968 |
| 62 | negative regulation of catecholamine secretion (GO:0033604) | 3.10025778 |
| 63 | sequestering of actin monomers (GO:0042989) | 3.08649040 |
| 64 | negative regulation of focal adhesion assembly (GO:0051895) | 3.08011503 |
| 65 | negative regulation of cell junction assembly (GO:1901889) | 3.08011503 |
| 66 | negative regulation of adherens junction organization (GO:1903392) | 3.08011503 |
| 67 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.07922838 |
| 68 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.01555347 |
| 69 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 3.01326415 |
| 70 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.00783186 |
| 71 | autophagic vacuole fusion (GO:0000046) | 2.99718222 |
| 72 | hematopoietic stem cell differentiation (GO:0060218) | 2.98499802 |
| 73 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.98380359 |
| 74 | purine-containing compound salvage (GO:0043101) | 2.96479508 |
| 75 | regulation of immunoglobulin secretion (GO:0051023) | 2.96130996 |
| 76 | negative regulation of interleukin-17 production (GO:0032700) | 2.94749192 |
| 77 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.92431571 |
| 78 | regulation of transmission of nerve impulse (GO:0051969) | 2.91638195 |
| 79 | platelet activation (GO:0030168) | 2.87818224 |
| 80 | megakaryocyte development (GO:0035855) | 2.86772031 |
| 81 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.86460952 |
| 82 | UV protection (GO:0009650) | 2.86207565 |
| 83 | granulocyte activation (GO:0036230) | 2.86082904 |
| 84 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.85359049 |
| 85 | angiogenesis involved in wound healing (GO:0060055) | 2.82142804 |
| 86 | synaptonemal complex organization (GO:0070193) | 2.81711515 |
| 87 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.80325620 |
| 88 | regulation of lymphocyte migration (GO:2000401) | 2.77888321 |
| 89 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.77409232 |
| 90 | positive regulation of B cell mediated immunity (GO:0002714) | 2.77409232 |
| 91 | DNA deamination (GO:0045006) | 2.77209572 |
| 92 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.73601310 |
| 93 | negative regulation of heart contraction (GO:0045822) | 2.73378610 |
| 94 | neuronal action potential propagation (GO:0019227) | 2.72533121 |
| 95 | positive regulation of isotype switching (GO:0045830) | 2.72285778 |
| 96 | forebrain morphogenesis (GO:0048853) | 2.71945679 |
| 97 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.71233530 |
| 98 | innate immune response in mucosa (GO:0002227) | 2.69961377 |
| 99 | platelet formation (GO:0030220) | 2.69593665 |
| 100 | activation of MAPKKK activity (GO:0000185) | 10.7528657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.87787297 |
| 2 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.35118985 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.80688709 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.73147885 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.57992241 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.25651291 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.20193530 |
| 8 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 3.04513333 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68247020 |
| 10 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.62513153 |
| 11 | STAT1_20625510_ChIP-Seq_HELA_Human | 2.60465456 |
| 12 | GATA1_19941826_ChIP-Seq_K562_Human | 2.48493184 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.41080328 |
| 14 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.12640920 |
| 15 | GATA2_19941826_ChIP-Seq_K562_Human | 2.09593329 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.07577042 |
| 17 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.07152443 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.05502731 |
| 19 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.01414537 |
| 20 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.92047077 |
| 21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.79178042 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73035451 |
| 23 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.71886732 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.69079467 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.67885041 |
| 26 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.66224153 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.57023495 |
| 28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52999941 |
| 29 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.50339446 |
| 30 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47604119 |
| 31 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39580925 |
| 32 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.39549755 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.39088992 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38862101 |
| 35 | AR_20517297_ChIP-Seq_VCAP_Human | 1.38456539 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.36129992 |
| 37 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.34509513 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33924053 |
| 39 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.33279421 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32943795 |
| 41 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.28542507 |
| 42 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.27093858 |
| 43 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.25920083 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25824206 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23571031 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20530627 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20433029 |
| 48 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16735850 |
| 49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15675684 |
| 50 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14783525 |
| 51 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.14510123 |
| 52 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.14510123 |
| 53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.13917992 |
| 54 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.12780950 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12552334 |
| 56 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11992398 |
| 57 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.09690424 |
| 58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09193654 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.07910306 |
| 60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.07769962 |
| 61 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06966725 |
| 62 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.06644018 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.05234910 |
| 64 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.05196100 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04500524 |
| 66 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03029274 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02834778 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02353023 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01583848 |
| 70 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.01536664 |
| 71 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.01043632 |
| 72 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00920933 |
| 73 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00829504 |
| 74 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99863043 |
| 75 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98805799 |
| 76 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98793987 |
| 77 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98696604 |
| 78 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98696604 |
| 79 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.98550745 |
| 80 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97980873 |
| 81 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.97933568 |
| 82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97230432 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97181915 |
| 84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96718256 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.95976004 |
| 86 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.95772522 |
| 87 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95179687 |
| 88 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94613859 |
| 89 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94012888 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92980763 |
| 91 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.92740539 |
| 92 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92251462 |
| 93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92099762 |
| 94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91336124 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90597892 |
| 96 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90176389 |
| 97 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90174469 |
| 98 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88062028 |
| 99 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87459996 |
| 100 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.86342504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005623_abnormal_meninges_morphology | 8.43649368 |
| 2 | MP0005464_abnormal_platelet_physiology | 7.32911220 |
| 3 | MP0008004_abnormal_stomach_pH | 3.73947724 |
| 4 | MP0000013_abnormal_adipose_tissue | 3.12941210 |
| 5 | MP0009384_cardiac_valve_regurgitation | 3.04014861 |
| 6 | MP0005671_abnormal_response_to | 2.93116887 |
| 7 | MP0000750_abnormal_muscle_regeneration | 2.80426428 |
| 8 | MP0005083_abnormal_biliary_tract | 2.78801499 |
| 9 | MP0000858_altered_metastatic_potential | 2.72587709 |
| 10 | MP0000343_altered_response_to | 2.58728781 |
| 11 | MP0003724_increased_susceptibility_to | 2.43244100 |
| 12 | MP0004947_skin_inflammation | 2.20447196 |
| 13 | MP0008775_abnormal_heart_ventricle | 2.15716434 |
| 14 | MP0004130_abnormal_muscle_cell | 2.10516378 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.05706698 |
| 16 | MP0005410_abnormal_fertilization | 2.00818191 |
| 17 | MP0002736_abnormal_nociception_after | 1.85269234 |
| 18 | MP0000465_gastrointestinal_hemorrhage | 1.81644349 |
| 19 | MP0002638_abnormal_pupillary_reflex | 1.71608954 |
| 20 | MP0000230_abnormal_systemic_arterial | 1.60354752 |
| 21 | MP0003786_premature_aging | 1.60183540 |
| 22 | MP0008872_abnormal_physiological_respon | 1.58276707 |
| 23 | MP0005646_abnormal_pituitary_gland | 1.52553864 |
| 24 | MP0005084_abnormal_gallbladder_morpholo | 1.43569608 |
| 25 | MP0004147_increased_porphyrin_level | 1.42552027 |
| 26 | MP0003638_abnormal_response/metabolism_ | 1.39482610 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.30080778 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.27993513 |
| 29 | MP0002938_white_spotting | 1.26238068 |
| 30 | MP0004084_abnormal_cardiac_muscle | 1.25343895 |
| 31 | MP0009764_decreased_sensitivity_to | 1.24617678 |
| 32 | MP0004215_abnormal_myocardial_fiber | 1.19163930 |
| 33 | MP0009765_abnormal_xenobiotic_induced | 1.18402008 |
| 34 | MP0004510_myositis | 1.18027778 |
| 35 | MP0003279_aneurysm | 1.16811790 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16250748 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.15757913 |
| 38 | MP0002102_abnormal_ear_morphology | 1.11463099 |
| 39 | MP0001800_abnormal_humoral_immune | 1.07277964 |
| 40 | MP0001663_abnormal_digestive_system | 1.06315867 |
| 41 | MP0001968_abnormal_touch/_nociception | 1.06098993 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.05823811 |
| 43 | MP0002723_abnormal_immune_serum | 1.05518180 |
| 44 | MP0009379_abnormal_foot_pigmentation | 1.05509143 |
| 45 | MP0009763_increased_sensitivity_to | 1.04945183 |
| 46 | MP0003828_pulmonary_edema | 1.04699976 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.01665391 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.00800913 |
| 49 | MP0003763_abnormal_thymus_physiology | 0.99334769 |
| 50 | MP0002132_abnormal_respiratory_system | 0.97900076 |
| 51 | MP0004036_abnormal_muscle_relaxation | 0.97161582 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 0.97041727 |
| 53 | MP0003879_abnormal_hair_cell | 0.96622799 |
| 54 | MP0002733_abnormal_thermal_nociception | 0.94970284 |
| 55 | MP0000685_abnormal_immune_system | 0.93419710 |
| 56 | MP0002452_abnormal_antigen_presenting | 0.93044713 |
| 57 | MP0002177_abnormal_outer_ear | 0.92482530 |
| 58 | MP0002398_abnormal_bone_marrow | 0.92104615 |
| 59 | MP0003866_abnormal_defecation | 0.91426870 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 0.91230484 |
| 61 | MP0006054_spinal_hemorrhage | 0.90633489 |
| 62 | MP0003303_peritoneal_inflammation | 0.90597723 |
| 63 | MP0000689_abnormal_spleen_morphology | 0.90458926 |
| 64 | MP0002420_abnormal_adaptive_immunity | 0.89927900 |
| 65 | MP0008874_decreased_physiological_sensi | 0.89712615 |
| 66 | MP0005501_abnormal_skin_physiology | 0.89556327 |
| 67 | MP0000249_abnormal_blood_vessel | 0.89276059 |
| 68 | MP0006276_abnormal_autonomic_nervous | 0.87351384 |
| 69 | MP0001819_abnormal_immune_cell | 0.86430742 |
| 70 | MP0001545_abnormal_hematopoietic_system | 0.85382492 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 0.85382492 |
| 72 | MP0005025_abnormal_response_to | 0.80727997 |
| 73 | MP0000003_abnormal_adipose_tissue | 0.80367961 |
| 74 | MP0002128_abnormal_blood_circulation | 0.78553121 |
| 75 | MP0002067_abnormal_sensory_capabilities | 0.77271796 |
| 76 | MP0005387_immune_system_phenotype | 0.76369459 |
| 77 | MP0001790_abnormal_immune_system | 0.76369459 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.74719896 |
| 79 | MP0002019_abnormal_tumor_incidence | 0.74107362 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.73566095 |
| 81 | MP0002722_abnormal_immune_system | 0.70956754 |
| 82 | MP0002429_abnormal_blood_cell | 0.70838507 |
| 83 | MP0002972_abnormal_cardiac_muscle | 0.70747843 |
| 84 | MP0003137_abnormal_impulse_conducting | 0.70633067 |
| 85 | MP0006292_abnormal_olfactory_placode | 0.69725947 |
| 86 | MP0001905_abnormal_dopamine_level | 0.68153001 |
| 87 | MP0004087_abnormal_muscle_fiber | 0.67919098 |
| 88 | MP0010329_abnormal_lipoprotein_level | 0.67809879 |
| 89 | MP0005385_cardiovascular_system_phenoty | 0.67181347 |
| 90 | MP0001544_abnormal_cardiovascular_syste | 0.67181347 |
| 91 | MP0005381_digestive/alimentary_phenotyp | 0.66004269 |
| 92 | MP0001851_eye_inflammation | 0.65946854 |
| 93 | MP0002234_abnormal_pharynx_morphology | 0.65615351 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.64142964 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.63346225 |
| 96 | MP0005058_abnormal_lysosome_morphology | 0.62441072 |
| 97 | MP0008873_increased_physiological_sensi | 0.62144231 |
| 98 | MP0003385_abnormal_body_wall | 0.61249721 |
| 99 | MP0000716_abnormal_immune_system | 0.61101506 |
| 100 | MP0003186_abnormal_redox_activity | 0.60025414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retinal atrophy (HP:0001105) | 9.60780279 |
| 2 | Cerebellar dysplasia (HP:0007033) | 8.78189774 |
| 3 | Type II lissencephaly (HP:0007260) | 7.53807125 |
| 4 | Fatigue (HP:0012378) | 7.45527807 |
| 5 | Hypoplasia of the pons (HP:0012110) | 6.87945976 |
| 6 | Retinal dysplasia (HP:0007973) | 6.68684719 |
| 7 | Prolonged bleeding time (HP:0003010) | 6.53270024 |
| 8 | Abnormality of the pons (HP:0007361) | 6.16097926 |
| 9 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 5.98680679 |
| 10 | Difficulty climbing stairs (HP:0003551) | 5.81588298 |
| 11 | Menorrhagia (HP:0000132) | 5.81171351 |
| 12 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 5.74253606 |
| 13 | Petechiae (HP:0000967) | 5.64341930 |
| 14 | Increased mean platelet volume (HP:0011877) | 5.54162906 |
| 15 | Buphthalmos (HP:0000557) | 5.51617084 |
| 16 | Abnormal platelet volume (HP:0011876) | 5.19008663 |
| 17 | Abolished electroretinogram (ERG) (HP:0000550) | 4.98695121 |
| 18 | Purpura (HP:0000979) | 4.95755143 |
| 19 | Epistaxis (HP:0000421) | 4.69496617 |
| 20 | Increased IgM level (HP:0003496) | 4.62313816 |
| 21 | Acanthocytosis (HP:0001927) | 3.96815647 |
| 22 | Gingival bleeding (HP:0000225) | 3.82210250 |
| 23 | Abnormal platelet function (HP:0011869) | 3.70245283 |
| 24 | Impaired platelet aggregation (HP:0003540) | 3.70245283 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 3.49018252 |
| 26 | Spontaneous hematomas (HP:0007420) | 3.41740053 |
| 27 | IgG deficiency (HP:0004315) | 3.29666980 |
| 28 | Congenital glaucoma (HP:0001087) | 3.16282807 |
| 29 | Entropion (HP:0000621) | 3.14530596 |
| 30 | Poikilocytosis (HP:0004447) | 3.10975837 |
| 31 | Severe muscular hypotonia (HP:0006829) | 3.07896783 |
| 32 | Intellectual disability, profound (HP:0002187) | 3.04988721 |
| 33 | Conjunctival telangiectasia (HP:0000524) | 3.03798308 |
| 34 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.96491359 |
| 35 | Generalized hypotonia (HP:0001290) | 2.90923785 |
| 36 | Dyschromatopsia (HP:0007641) | 2.88830996 |
| 37 | Gowers sign (HP:0003391) | 2.75816988 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 2.66178268 |
| 39 | Megalocornea (HP:0000485) | 2.65684676 |
| 40 | Lissencephaly (HP:0001339) | 2.63674953 |
| 41 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.58571387 |
| 42 | Generalized muscle weakness (HP:0003324) | 2.57839491 |
| 43 | Paralysis (HP:0003470) | 2.55116239 |
| 44 | Severe global developmental delay (HP:0011344) | 2.54034180 |
| 45 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.51053602 |
| 46 | Poikiloderma (HP:0001029) | 2.43656982 |
| 47 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.39829907 |
| 48 | Stomatitis (HP:0010280) | 2.39504769 |
| 49 | Abnormality of vision evoked potentials (HP:0000649) | 2.37156859 |
| 50 | Decreased central vision (HP:0007663) | 2.31392557 |
| 51 | Hypoplasia of the brainstem (HP:0002365) | 2.31163965 |
| 52 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.31163965 |
| 53 | Papilledema (HP:0001085) | 2.25026925 |
| 54 | Abnormality of DNA repair (HP:0003254) | 2.24440376 |
| 55 | Pachygyria (HP:0001302) | 2.23959589 |
| 56 | Abnormal pupillary function (HP:0007686) | 2.11571987 |
| 57 | Eosinophilia (HP:0001880) | 2.09986298 |
| 58 | Mesangial abnormality (HP:0001966) | 2.06016018 |
| 59 | Submucous cleft hard palate (HP:0000176) | 2.01692858 |
| 60 | IgA deficiency (HP:0002720) | 2.01497592 |
| 61 | Encephalitis (HP:0002383) | 1.95457003 |
| 62 | Tinnitus (HP:0000360) | 1.94067240 |
| 63 | Fragile nails (HP:0001808) | 1.92091421 |
| 64 | Abnormality of the vitreous humor (HP:0004327) | 1.91186629 |
| 65 | Bruising susceptibility (HP:0000978) | 1.90220639 |
| 66 | Nausea (HP:0002018) | 1.86968662 |
| 67 | Decreased subcutaneous fat (HP:0001002) | 1.86873839 |
| 68 | Ileus (HP:0002595) | 1.86080393 |
| 69 | Hepatosplenomegaly (HP:0001433) | 1.85846447 |
| 70 | Abnormality of incisor morphology (HP:0011063) | 1.84896979 |
| 71 | Meningocele (HP:0002435) | 1.82279083 |
| 72 | Abnormality of macrophages (HP:0004311) | 1.79735758 |
| 73 | Joint swelling (HP:0001386) | 1.79429275 |
| 74 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77952619 |
| 75 | Pallor (HP:0000980) | 1.77232560 |
| 76 | Joint hemorrhage (HP:0005261) | 1.73871138 |
| 77 | Granulocytopenia (HP:0001913) | 1.72951744 |
| 78 | Male infertility (HP:0003251) | 1.72640888 |
| 79 | Muscular dystrophy (HP:0003560) | 1.69999312 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 1.69483001 |
| 81 | Spontaneous abortion (HP:0005268) | 1.66753478 |
| 82 | Keratitis (HP:0000491) | 1.64214190 |
| 83 | Erythroderma (HP:0001019) | 1.60832363 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 1.57026293 |
| 85 | Muscle stiffness (HP:0003552) | 1.54887588 |
| 86 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.52802546 |
| 87 | Non-midline cleft lip (HP:0100335) | 1.51694325 |
| 88 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.49254505 |
| 89 | Abnormal auditory evoked potentials (HP:0006958) | 1.49116233 |
| 90 | Abnormality of eosinophils (HP:0001879) | 1.44898464 |
| 91 | Xanthomatosis (HP:0000991) | 1.43922169 |
| 92 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.43370388 |
| 93 | Increased density of long bones (HP:0006392) | 1.42767945 |
| 94 | Basal ganglia calcification (HP:0002135) | 1.42686398 |
| 95 | Infertility (HP:0000789) | 1.41640988 |
| 96 | Leukocytosis (HP:0001974) | 1.39233788 |
| 97 | Death in childhood (HP:0003819) | 1.37871755 |
| 98 | Acute necrotizing encephalopathy (HP:0006965) | 1.35701589 |
| 99 | Supranuclear gaze palsy (HP:0000605) | 1.34627321 |
| 100 | Slow saccadic eye movements (HP:0000514) | 1.34376623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK3 | 7.31902616 |
| 2 | STK10 | 6.76881368 |
| 3 | PTK2B | 3.80118337 |
| 4 | MST4 | 3.09358200 |
| 5 | RIPK4 | 2.86876803 |
| 6 | LMTK2 | 2.78539505 |
| 7 | PIM1 | 2.58013206 |
| 8 | TXK | 2.43942385 |
| 9 | BMX | 2.41008959 |
| 10 | TEC | 2.20149592 |
| 11 | MYLK | 2.15513837 |
| 12 | BTK | 2.00004057 |
| 13 | STK11 | 1.98362959 |
| 14 | CSF1R | 1.83665281 |
| 15 | PIK3CG | 1.57767210 |
| 16 | NLK | 1.57365198 |
| 17 | TESK2 | 1.47619296 |
| 18 | EIF2AK1 | 1.43648402 |
| 19 | ZAP70 | 1.39342844 |
| 20 | ADRBK2 | 1.38401325 |
| 21 | TAOK2 | 1.32123299 |
| 22 | SYK | 1.31058726 |
| 23 | TLK1 | 1.26737699 |
| 24 | IKBKB | 1.22776929 |
| 25 | GRK5 | 1.21636606 |
| 26 | EPHA3 | 1.20725048 |
| 27 | TAOK3 | 1.11445685 |
| 28 | BRSK2 | 1.09075198 |
| 29 | CAMKK2 | 1.08171623 |
| 30 | MAP4K1 | 1.04854565 |
| 31 | ILK | 1.03538402 |
| 32 | TNIK | 0.99309450 |
| 33 | GRK6 | 0.88588784 |
| 34 | HCK | 0.86360573 |
| 35 | MAP2K3 | 0.86239188 |
| 36 | BMPR2 | 0.84986270 |
| 37 | LYN | 0.80179677 |
| 38 | IRAK3 | 0.79554672 |
| 39 | IRAK1 | 0.76464086 |
| 40 | PKN1 | 0.76303059 |
| 41 | PIK3CA | 0.75274121 |
| 42 | TNK2 | 0.73967335 |
| 43 | PLK2 | 0.73424447 |
| 44 | STK3 | 0.72345283 |
| 45 | FRK | 0.69598063 |
| 46 | FGR | 0.67530398 |
| 47 | MAPKAPK3 | 0.63593498 |
| 48 | KDR | 0.62255145 |
| 49 | ITK | 0.61380616 |
| 50 | TAOK1 | 0.60834450 |
| 51 | MAP3K11 | 0.60108411 |
| 52 | DAPK3 | 0.59997565 |
| 53 | LCK | 0.59718610 |
| 54 | TRIM28 | 0.59391393 |
| 55 | MATK | 0.58764286 |
| 56 | YES1 | 0.58750947 |
| 57 | FER | 0.57817985 |
| 58 | MAP4K2 | 0.54350465 |
| 59 | PRKCH | 0.53631659 |
| 60 | MAP3K5 | 0.52638976 |
| 61 | FES | 0.52371647 |
| 62 | PRKD1 | 0.52297787 |
| 63 | GSK3A | 0.52292498 |
| 64 | ADRBK1 | 0.51585491 |
| 65 | ACVR1B | 0.47534109 |
| 66 | STK4 | 0.45834493 |
| 67 | MAP3K3 | 0.44336940 |
| 68 | STK24 | 0.43739797 |
| 69 | PRKACG | 0.43283536 |
| 70 | FYN | 0.42028896 |
| 71 | PAK1 | 0.41906658 |
| 72 | BMPR1B | 0.41278080 |
| 73 | CSK | 0.38719183 |
| 74 | PIM2 | 0.36919967 |
| 75 | PRKCE | 0.36484697 |
| 76 | PDK1 | 0.34757708 |
| 77 | GRK1 | 0.33782478 |
| 78 | IGF1R | 0.32513158 |
| 79 | VRK1 | 0.32436826 |
| 80 | ERBB2 | 0.32014152 |
| 81 | ZAK | 0.31967887 |
| 82 | MAPK11 | 0.31845879 |
| 83 | PRKCD | 0.31562579 |
| 84 | DAPK2 | 0.31072603 |
| 85 | PRKCQ | 0.30803864 |
| 86 | MELK | 0.28394250 |
| 87 | PDPK1 | 0.27540028 |
| 88 | TIE1 | 0.27443066 |
| 89 | PRKG1 | 0.27302500 |
| 90 | RET | 0.27263142 |
| 91 | BLK | 0.26698606 |
| 92 | CSNK1G3 | 0.26558668 |
| 93 | CSNK1D | 0.26455598 |
| 94 | RPS6KA5 | 0.26301838 |
| 95 | PRKCA | 0.22429250 |
| 96 | HIPK2 | 0.21005203 |
| 97 | PRKD2 | 0.21004328 |
| 98 | NUAK1 | 0.20919010 |
| 99 | DYRK1A | 0.20721186 |
| 100 | PRKG2 | 0.20483438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 5.79568625 |
| 2 | Platelet activation_Homo sapiens_hsa04611 | 3.63042983 |
| 3 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 3.48621345 |
| 4 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.33759836 |
| 5 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.18678452 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.08807834 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.06557696 |
| 8 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.95779794 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.92257816 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 1.88097956 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.86438531 |
| 12 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.71537325 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69266379 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.56091561 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53290341 |
| 16 | Alcoholism_Homo sapiens_hsa05034 | 1.52751165 |
| 17 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.48217917 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.46320549 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.42202780 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39014596 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37082429 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34817750 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.34689569 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.34072863 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33393146 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29179034 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27734287 |
| 28 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.26642461 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.19374497 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19189689 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15232389 |
| 32 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.11974308 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10963026 |
| 34 | Ribosome_Homo sapiens_hsa03010 | 1.08766116 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07756462 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06582290 |
| 37 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03846190 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03183454 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 1.00197970 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96824133 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96124610 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94733189 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94509343 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 0.92536082 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.86658403 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85921236 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84712074 |
| 48 | Gap junction_Homo sapiens_hsa04540 | 0.76364854 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76319181 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74732781 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 0.73461790 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71550301 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.70203395 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69823648 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.69178471 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68045126 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66943125 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 0.66069541 |
| 59 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65331406 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63191033 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.60674338 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59418445 |
| 63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58313596 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58289148 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58046903 |
| 66 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57740368 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57257093 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56688053 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56402584 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.52509230 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51907125 |
| 72 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50279175 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49940014 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48401003 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48396146 |
| 76 | Purine metabolism_Homo sapiens_hsa00230 | 0.47902121 |
| 77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47662486 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46653949 |
| 79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46513271 |
| 80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45800735 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45487348 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45042645 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44133974 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43406831 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.43030500 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41918075 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.41310217 |
| 88 | GABAergic synapse_Homo sapiens_hsa04727 | 0.40399054 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39062793 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38628493 |
| 91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.37602838 |
| 92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37041580 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37016096 |
| 94 | Morphine addiction_Homo sapiens_hsa05032 | 0.35665453 |
| 95 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33899630 |
| 96 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33687418 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.33570115 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.33143881 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33088137 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32991528 |

